Company profile
advanceCOR company profile
advanceCOR is a clinical drug developing company that focuses on therapeutics and diagnostics for heart and vascular diseases. Its products include Revacept, a human Fc fusion protein, which prevents the local activation of platelets at sites of vascular injury; COR-2, a recombinant protein that interferes with the generation of foam cells; and COR-3, a recombinant protein, which specifically binds to atherosclerotic plaques, and then bi-specifically binds to circulating progenitor cells to trap the endogenously occurring progenitor cells for accelerated plaque healing.
Business identity
- Website
- http://www.advancecor.de/
- Contact email
- [email protected]
- Phone number
- +498985652010
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $0+
- Founded
- 2012-01-01
Headquarters
- Headquarters
- Munich, Bavaria, Germany
- Postal code
- 82152
- Country code
- DE
- Continent
- Europe